Skip to main content

Day: August 12, 2020

Pieridae Announces Second Quarter Results

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES ORDISSEMINATION IN UNITED STATESHighlights:Revenue of $68.6 million in Q2 2020, an increase of $55.2 million or 412% compared to Q2 2019Net operating income1 (“NOI”) increased by $21.2 million or 1,101% compared to Q2 2019Adjusted Funds Flow From Operations1 (“AFFO”) increased by $19.0 million or 291% compared to Q2 2019Q2 2020 average production was 43,791 barrels of oil equivalent per day (“boe/day”), an increase of 28,423 boe/day or 185% compared to Q2 2019CALGARY, Alberta , Aug. 12, 2020 (GLOBE NEWSWIRE) — Pieridae Energy Limited (“Pieridae” or the “Company”) (PEA.TO) released its Q2 2020 results today, highlighted by the fact the Company continues to deliver solid results quarter after quarter, achieving strong metrics in overall revenue, NOI, AFFO and daily production....

Continue reading

Amerigo Reports Q2-2020 Financial Results

$2.8 million cash generated from operations in the quarterQuarterly net loss down to $3.6 million ($0.02 LPS)Lower tolling & production costs, cash cost and total costVANCOUVER, British Columbia, Aug. 12, 2020 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (TSX: ARG) (“Amerigo” or the “Company”) announced financial results for the quarter ended June 30, 2020 (“Q2-2020”). Net loss was $3.6 million (Q2-2019: $6.6 million) from higher revenue and lower tolling and production costs at MVC (Minera Valle Central, the Company’s 100% owned operation located near Rancagua, Chile). Loss per share during Q2-2020 was $0.02 (Q2-2019: $0.04). MVC’s average copper price in Q2-2020 was $2.61 per pound (“/lb”) (Q2-2019: $2.67/lb).The Company generated $2.8 million in operating cash flow before changes in non-cash working capital in Q2-2020 (Q2-2019:...

Continue reading

Lantronix Open-Q 610 μSOM to Bring Advanced AI and Machine Learning Capabilities to Smart Cameras

IRVINE, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) — Lantronix, Inc. (NASDAQ: LTRX), a global provider of intelligent edge and secure data management solutions for the Industrial Internet of Things (IoT), today announced its new Lantronix Open-Q™ 610 μSOM. Scheduled for delivery later this year, the advanced Lantronix Open-Q 610 μSOM will be aimed at connected visual intelligence applications with high-resolution camera capabilities, on-device artificial intelligence (AI) processing and native Ethernet interface.“Lantronix micro SOMs and solutions enable IoT device makers to jumpstart new product development and accelerate time-to-market by shortening the design cycle, reducing development risk and simplifying the manufacturing process,” said Paul Pickle, CEO of Lantronix.The new Lantronix ultra-compact (50mm x 25mm), production-ready...

Continue reading

Ascendis Pharma A/S Receives Orphan Designation for TransCon™ CNP for the Treatment of Achondroplasia in Europe

COPENHAGEN, Denmark, Aug. 12, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced the European Commission (EC) has granted Orphan Designation to TransCon C-Type Natriuretic Peptide (CNP) for the treatment of achondroplasia, the most common form of dwarfism.1  TransCon CNP is a investigational long-acting prodrug of CNP, designed to provide continuous exposure of CNP at safe, therapeutic levels via a single, weekly subcutaneous dose.  TransCon CNP also received orphan designation for the treatment of achondroplasia in the United States (U.S.) in February 2019.  Currently, there is no medical therapy approved for the treatment of achondroplasia.2“We now have orphan designations in Europe and the U.S....

Continue reading

Sompo International Appoints New Head of Cyber for London Market Business

PEMBROKE, Bermuda, Aug. 12, 2020 (GLOBE NEWSWIRE) — Sompo International Holdings Ltd., a Bermuda-based specialty provider of property and casualty insurance and reinsurance, has appointed Mrs. Lauren Folkard, Vice President and Head of Cyber for the London Market. Mrs. Folkard was previously a cyber class underwriter at Barbican and is an industry veteran, having been part of the cyber management team at Chubb. She will be based out of the firm’s London office.Mr. Julian James, Chief Executive Officer, International Insurance at Sompo International, commented, “We are delighted to welcome Lauren to Sompo International. This is an exciting development as part of our long-term commitment to this class of business and it supplements our global cyber capabilities. While clients already face a wide range of cyber exposures, they have...

Continue reading

Kamada Reports Second Quarter and First Six Months of 2020 Financial Results, Recent Corporate Achievements and Strong Cash Position  

Second Quarter Revenues were $33.1 million, Compared to $35.3 million in 2019, First Half 2020 Revenues were $66.4 million, up 7% from 2019 Net Income for the Second Quarter and for the First Half of 2020 was $3.5 million and $8.7 million, Respectively, Compared to $6.1 million and $11.1 million in 2019 RespectivelySignificant Progress Achieved in Development of a Plasma-Derived Immunoglobulin (IgG) Product as a Potential Treatment for Coronavirus Disease (COVID-19)Approximately $100 million of Available Net Cash as of June 30, 2020Exploring Business Development Initiatives Targeted to Mitigate the Effect of the Planned Transition of GLASSIA® Manufacturing to Takeda During 2021Company Reiterates Full-Year 2020 Total Revenue Guidance of $132 Million to $137 MillionREHOVOT, Israel, Aug. 12, 2020 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ:...

Continue reading

AGTC Formalizes Patient Advisory Council to Provide Insights and Guidance on Patient Perspectives for Pipeline Therapies

Patient Advisory Council to include advocates from the inherited retinal diseases global community New Patient Advisory Council to focus initially on Company’s clinical stage programs for X-linked retinitis pigmentosa (XLRP)GAINESVILLE, Fla., and CAMBRIDGE, Mass., Aug. 12, 2020 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company focused on developing adeno-associated virus (AAV) based gene therapies for the treatment of rare inherited diseases, today announced the formation of a Patient Advisory Council to build on its focus of incorporating the patient and caregiver voice into the Company’s culture and clinical and pre-clinical programs.Engagement with patients and caregivers has provided AGTC with substantive information that has guided its clinical trial design, enhanced its understanding...

Continue reading

Trillium Therapeutics Reports Second Quarter 2020 Financial and Operating Results

TTI-621 study has progressed to the 2.0 mg/kg dosing levelTTI-622 showing early evidence of monotherapy activity$130.8 million of cash and investments as of June 30, 2020CAMBRIDGE, Mass., Aug. 12, 2020 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today reported financial and operating results for the six months ended June 30, 2020.“We had a strong quarter, further advancing dose escalation of our lead candidates TTI-621 and TTI-622. After an initial slow-down in TTI-621 patient enrollment due to Covid-19, we successfully completed safety assessment of the 1.4 mg/kg cohort at the end of July, and moved up to 2.0 mg/kg dosing”, said Jan Skvarka, Trillium’s President and Chief Executive...

Continue reading

GBT Tokenize Completed First Phase of qTerm – Shape and Sizes

SAN DIEGO, Aug. 12, 2020 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT” or the “Company”), announced that its Joint Venture, GBT Tokenize Corp (“GBT/Tokenize”), has completed Phase I of qTerm, a human vitals device, powered by AI, which is the device size and physical dimensions.The qTerm device is targeted to measure body temperature, blood pressure, and heart rate – all with a simple touch of the finger. GBT believes that the miniaturization of the device is a key factor to its success, yet advanced circuitry and sensory systems have to fit on board. We simulated and evaluated sizes and shapes of qTerm and concluded a user friendly, efficient sizes and shape for version one.  The device could be easily attached to a smart phone or used as a standalone instrument. Version one will use a standard button battery...

Continue reading

Society6 Sees Strongest Month in Company History with $17.1 Million in Gross Transaction Value in July

SANTA MONICA, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) — Society6 today announced record-setting Gross Transaction Value (GTV) of $17.1 million – a 144% increase year-over-year – for July 2020, marking the brand’s strongest month in company history.  In July, Society6 saw strong growth in its Art Prints, Bedding and Home Decor categories as customer purchase behavior continues to rapidly shift to online in the home decor market. The artist-driven online marketplace, featuring made-to-order products in home decor, wall art, apparel and accessories, launched its annual Back-to-School campaign in July, while continuing to invest in improvements for the mobile user experience, with updates including new department and category pages and a redesigned shopping cart and checkout process.For this year’s Back-to-School campaign, Society6 took...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.